Symbol="VTYX"
AssetType="Common Stock"
Name="Ventyx Biosciences Inc"
Description="Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company is headquartered in Encinitas, California."
CIK="1851194"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="662 ENCINITAS BLVD., STE. 250, ENCINITAS, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1852040000"
EBITDA="-169544992"
PERatio="None"
PEGRatio="None"
BookValue="5.58"
DividendPerShare="0"
DividendYield="0"
EPS="-2.84"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.347"
ReturnOnEquityTTM="-0.553"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.84"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="56.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="5.01"
EVToRevenue="-"
EVToEBITDA="-16.69"
Beta="None"
num_52WeekHigh="47.25"
num_52WeekLow="19.73"
num_50DayMovingAverage="34.25"
num_200DayMovingAverage="34.8"
SharesOutstanding="58888000"
DividendDate="None"
ExDividendDate="None"
symbol="VTYX"
open="32.35"
high="32.66"
low="31.08"
price="31.45"
volume="301264.00"
latest_trading_day="2023-08-24"
previous_close="32.44"
change="-0.99"
change_percent="-3.0518%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="60"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="734817"
Change_recent_avg="0.05"
Delta_recent_avg="1.8"
Variance_recent_avg="0.9"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="115"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0061.jpeg"
image_negative_thumbnail_id_2="108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="1015"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_positive_thumbnail_id_2="619"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
